Impact of induction therapy on cytomegalovirus infection and post-transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis.

Suhua ZangXin ZhangJianli Niu Bibhuti B Das

Published in: Clinical transplantation (2022)

In conclusion, induction with ATG was associated with reduction in risk of rejection at 1 year with no effects on CMV infection, CAV, and mortality in pediatric heart transplant recipients with universal antiviral prophylaxis compared with basiliximab induction therapy.

Keyphrases

heart failure
atrial fibrillation
cardiovascular events
type diabetes
risk factors
metabolic syndrome
coronary artery disease
cell therapy
skeletal muscle